| Financial Year |
March 31 2023 |
| Monetary Funds |
244,170,525.09 |
| Held-for-trading Financial Assets |
760,070,901.06 |
| Notes Receivable |
-- |
| Accounts Receivable |
235,705,470.17 |
| Advances to Suppliers |
23,703,571.36 |
| Other Receivables |
127,076,596.91 |
| Amounts Due From Related Companies |
-- |
| Interest Receivable |
-- |
| Dividend Receivable |
-- |
| Inventories |
371,766,855.74 |
| Among: Consumptive Biological Assets |
-- |
| Non-Current Assets Maturing Within One Year |
-- |
| Other Current Assets |
81,846,325.38 |
| Total Current Assets |
1,844,340,245.71 |
| Available-for-Sale Financial Asset |
-- |
| Held-to-maturity Investments |
-- |
| Long-Term Account Receivable |
-- |
| Long-term Equity Investment |
111,703,118.76 |
| Investment Properties |
-- |
| Fixed Assetes |
289,223,321.24 |
| Under-construction Projects |
5,590,811.04 |
| Construction Materials |
-- |
| Disposal of Fixed Assets |
-- |
| Capitalized Biological Assets |
-- |
| Oil and Gas Assets |
-- |
| Intangible Assets |
34,639,032.29 |
| R&D expenses |
-- |
| Goodwill |
-- |
| Long-Term Deferred and Prepaid Expenses |
1,358,370.98 |
| Deferred Income Tax Assets |
9,465,934.27 |
| Other Non-Current Assets |
6,016.81 |
| Sub-Total of Non-Current Assets |
458,927,255.78 |
| Total Assets |
2,303,267,501.49 |
| Short-Term Loans |
-- |
| Trading Financial liabilities |
-- |
| Notes Payable |
-- |
| Accounts Payable |
192,668,926.04 |
| Accounts Received In Advance |
-- |
| Employee Compensation Payable |
1,404,472.34 |
| Taxes Payable |
14,741,167.52 |
| Interest Payable |
-- |
| Dividend Payable |
-- |
| Other payables |
3,388,801.38 |
| Due to Related Companies |
-- |
| Non-Current Liabilities Due Within One Year |
21,367,141.19 |
| Other Current Liabilities |
3,257,013.61 |
| Sub-Total of Current Liabilities |
268,113,150.30 |
| Long-term Loans |
36,000,000.00 |
| Bonds Payable |
-- |
| Long-Term Accounts Payable |
-- |
| Special Payable |
-- |
| Estimatied Liabilities |
-- |
| Deferred Income Tax Liabilities |
4,597,046.48 |
| Other Non-Current Liabilities |
-- |
| Sub-Total of Non-Current Liabilities |
43,300,232.35 |
| Total Liabilities |
311,413,382.65 |
| Paid-In Capital(Or Share Stock) |
700,649,154.00 |
| Capital Surplus |
34,372,434.07 |
| Surplus Reserve |
222,226,182.86 |
| LESS:Treasury Stock |
-- |
| Undistributed Profits |
1,031,907,965.40 |
| Minority Stockholder's Interest |
-- |
| Foreign Currency Capital |
-- |
| Abnormal Management Project Income Adjusted |
-- |
| Total Owners' Equity Attributable to Parent(Stockholder's Interest) |
1,991,854,118.84 |
| Owner's Equity（Stockholder's Equity） |
1,991,854,118.84 |
| Total Liabilities and Owner's Equity（Stockholder's Equity） |
2,303,267,501.49 |
